The patient's second brain biopsy pathology contained findings compatible with PCNSL, evidenced by immunohistochemistry, immunoglobulin gene rearrangement, and MYD88 L265P mutation corresponding to lymphoid malignancies. Here, MYD88 is linked to primary central nervous system lymphoma.